跳至主要内容
临床试验/JPRN-UMIN000028623
JPRN-UMIN000028623已完成未知

Study on the interaction between barley beta-glucan and pharmaceutical products - Study on the interaction between barley beta-glucan and pharmaceutical products

akakinen Clinic Medical corporation kensei-kai0 个研究点目标入组 30 人开始时间: 2017年8月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Serious ketosis, diabetic coma or precoma, patients with dialysis and type 1 diabetic patients. (2) Patients with diseases or trauma such as serious infection, before and after surgery, cancer, etc. (3) Those who are taking hypoglycemic drugs except the drugs listed in the selection criteria. (4) Persons who merged gastrointestinal disorders affecting digestion / absorption. (5) Persons who have a medical history of gastrointestinal resection. (6) Persons who merged serious liver and kidney problems (as judged by a doctor). (7) Persons who developed myocardial infarction / stroke within 180 days before D0. (8) Persons who take systemic steroids (excluding local). (9) Smokers. (10) Persons who are drinking excessively (For example, 180 mL or more of sake per day, three or more big bottles of beer per day). (11) Persons who have a history of hypersensitivity (food allergy etc.) to the test meals (barley, rice, wheat, milk ingredients, apples, beef, pork, soybeans and sesame). (12) Persons who usually consume barley. (13) Pregnant women or ladies who may be pregnant. (14) Others who are judged inappropriate by the representative doctor.

研究者

发起方
akakinen Clinic Medical corporation kensei-kai

相似试验

Study on the interaction between barley beta-glucan... | 临床试验